[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
January 13, 2010

Price Hikes Probed

JAMA. 2010;303(2):125. doi:10.1001/jama.2009.1954

At a December 8 hearing, the House Committee on Energy and Commerce’s Subcommittee on Health explored recent price hikes by pharmaceutical manufacturers that appear to anticipate pending health system reform legislation that could affect drug costs.

Stephen W. Schondelmeyer, PhD, PharmD, of the University of Minnesota in Minneapolis, testified that he estimated that brand-name prescription drug prices increased an average of 9.3% in the 12-month period that culminated at the end of September 2009, while general inflation decreased by only 0.3%.

First Page Preview View Large
First page PDF preview
First page PDF preview
×